HealthTree®

IMPROVING MYELOMA PATIENT OUTCOMES AND ACCELERATING A CURE

LIFE WITH MYELOMA

Connect With the Myeloma Crowd On Social Media: Together We’re Stronger

Jan 23, 2020
The Myeloma Crowd has numerous ways to connect with other patients and caregivers. We believe that when we are together, we are stronger. Everyone has a story and through our social media channels you...
ADVERTISEMENT
CLINICAL TRIALS

ASH 2019:  Thank you Daratumumab: The Era of Four Drug Upfront Therapy for Newly Diagnosed Patie...

Dec 17, 2019
On the final day of ASH there were many presentations of four-drug studies where daratumumab has been added to backbone triplets...
SIGN UP FOR OUR
NEWSLETTER
Get the latest thought leadership on multiple myeloma delivered straight to your inbox.

GO

LIFE WITH MYELOMA
Jan 22, 2020
– – –  January is Myeloma Crowd Month! In...
MYELOMA CROWD RADIO

Our Next Show: Multiple Myeloma Innovation in 2020 with Robert Orlowski, MD, PhD, MD Anderson Thursday, January 30, 2...

Jan 22, 2020
Thursday, January 30 @ 9 am Pacific, 10 am Mountain, 11 am Central, Noon Eastern Call In by Phone to...
MYELOMA CROWD RESEARCH INITIATIVE
$207200 of $500,000 Raised
BRINGING THE RIGHT TREATMENT TO THE PATIENT AT THE RIGHT TIME
Please Help Us Reach Our Goal
MYELOMA 101

Myeloma 101: How is Active Multiple Myeloma Defined?

Jan 23, 2020
How is active myeloma defined? CRAB In the past, multiple myeloma was defined by four important “CRAB” features: Calcium, Renal, Anemia, and Bone...
MUSCLES FOR MYELOMA

Muscles for Myeloma: Living a Normal Life

Oct 02, 2019
September was Blood Cancer Awareness month and time to focus on how some myeloma patients are developing Muscles for Myeloma. Staying fit is critical for your best myeloma outcomes. Every patient will be different in what they can do, so talk with...
CLINICAL TRIALS

IMW 2019: The New GSK Antibody Drug Conjugate in Myeloma

Oct 02, 2019
An antibody drug conjugate is a type of immunotherapy being explored in multiple myeloma. Glaxo-Smith Klein is developing a new antibody drug conjugate in myeloma called Belantamab mafodotin (or “belmaf” for short). These drugs...

FIND

Myeloma Financial Resource
FINANCIAL
RESOURCES
Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.
Go
Myeloma Specialist
MYELOMA
SPECIALISTS
Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.
Go
Myeloma Clinical Trials
CLINICAL
TRIALS
Today's myeloma therapies are yesterday's clinical trials and if more patients joined, we could accelerate a cure.Find a trial that's right for you using a myeloma clinical trial finder called SparkCures.
Go

MYELOMA CROWD RESEARCH INITIATIVE

The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. The goal of the MCRI is to find and fund a cure for multiple myeloma.
Learn More >

Thanks to our site sponsors: